ACUTE BIPHENOTYPIC LEUKAEMIA

ACUTE BIPHENOTYPIC LEUKAEMIA was reported 93 times

These drug classes are most commonly taken by patients reporting ACUTE BIPHENOTYPIC LEUKAEMIA:

# Drug Count
0 Corticosteroid [EPC] 33
1 Alkylating Drug [EPC] 20
2 CD20-directed Cytolytic Antibody [EPC] 11
3 Nonsteroidal Anti-inflammatory Drug [EPC] 11
4 Thalidomide Analog [EPC] 11
5 Calcium Channel Blocker [EPC] 10
6 Dihydropyridine Calcium Channel Blocker [EPC] 10
7 Nucleoside Metabolic Inhibitor [EPC] 10
8 Proteasome Inhibitor [EPC] 9
9 Azole Antifungal [EPC] 8
10 BCL-2 Inhibitor [EPC] 8
11 Microtubule Inhibitor [EPC] 8
12 Platinum-based Drug [EPC] 7
13 Calcineurin Inhibitor Immunosuppressant [EPC] 5
14 Folate Analog Metabolic Inhibitor [EPC] 4
15 Kinase Inhibitor [EPC] 4
16 Leukocyte Growth Factor [EPC] 4
17 Topoisomerase Inhibitor [EPC] 4
18 Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
19 Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
20 Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 3
21 Antimetabolite [EPC] 2
22 Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] 2
23 Echinocandin Antifungal [EPC] 2
24 Immunoglobulin G [EPC] 2
25 Nucleoside Analog Antiviral [EPC] 2
26 CD22-directed Immunoconjugate [EPC] 1
27 Dihydrofolate Reductase Inhibitor Antibacterial [EPC] 1
28 Endothelin Receptor Antagonist [EPC] 1
29 General Anesthetic [EPC] 1
30 Glycopeptide Antibacterial [EPC] 1
31 HER2/neu Receptor Antagonist [EPC] 1
32 Histamine-2 Receptor Antagonist [EPC] 1
33 Insulin [EPC] 1
34 Interleukin-4 Receptor alpha Antagonist [EPC] 1
35 Iron Chelator [EPC] 1
36 Janus Kinase Inhibitor [EPC] 1
37 Loop Diuretic [EPC] 1
38 Opioid Agonist [EPC] 1
39 Osmotic Diuretic [EPC] 1
40 Tumor Necrosis Factor Blocker [EPC] 1
41 Xanthine Oxidase Inhibitor [EPC] 1